Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H7AR
|
|||
Former ID |
DIB006486
|
|||
Drug Name |
MK-51
|
|||
Synonyms |
MK-52; MK-52); Moderately potent glucocorticoid (topical (SILEC), skin disease), MIKA; Potent glucocorticoid (topical (SILEC), skin disease), MIKA
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Dermatological disease [ICD-11: DA24.Y] | Phase 1 | [1] | |
Company |
MIKA Pharma GmbH
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H25N3O
|
|||
Canonical SMILES |
C1CC(N(C1)CC2=CC=CC3=CC=CC=C32)C(=O)NCC4=CNC5=CC=CC=C54
|
|||
InChI |
1S/C25H25N3O/c29-25(27-16-20-15-26-23-12-4-3-11-22(20)23)24-13-6-14-28(24)17-19-9-5-8-18-7-1-2-10-21(18)19/h1-5,7-12,15,24,26H,6,13-14,16-17H2,(H,27,29)/t24-/m0/s1
|
|||
InChIKey |
CUWTVICBYHBSOX-DEOSSOPVSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of MIKA Pharma GmbH. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.